Friday, 29 March 2024
Mersana Therapeutics Inc.
NASDAQ : MRSN
6.580 14 Oct 22 00:00 | Change: 0.33 | Open: 6.970 | High: 7.270 | Ask: 0.000 | Volume: 931,700 |
Change(%): 4.78 | Prev: 6.910 | Low: 6.520 | Bid: 0.000 | Avg vol: 0 |
More notable recent Mersana Therapeutics, Inc. (NASDAQ:MRSN) news were published by: Seekingalpha.com which released: “Mersana Therapeutics Kicks Off A Major IPO Week” on June 26, 2017, also Bostonglobe.
more»
01:00 | 3/2/18
The Ledger Gazette
Mersana Therapeutics (NASDAQ:MRSN) was upgraded by research analysts at ValuEngine from a “strong sell” rating to a “sell” rating in a report released on Friday.
more»
05:52 | 23/1/18
Frisco Fastball
More notable recent Mersana Therapeutics, Inc. (NASDAQ:MRSN) news were published by: Businesswire.com which released: “Mersana Therapeutics Appoints Andrew AF Hack, MD, Ph.
more»
22:45 | 13/1/18
Frisco Fastball
Analysts expect Mersana Therapeutics, Inc. (NASDAQ:MRSN) to report $-0.50 EPS on February, 8.After having $-0.35 EPS previously, Mersana Therapeutics, Inc.'s analysts see 42.86 % EPS growth. The stock decreased 2.89% or $0.46 during the last trading ...
more»
01:56 | 9/1/18
GlobeNewswire
CAMBRIDGE, Mass., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc., (NASDAQ:MRSN) a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates (ADCs) based on its Dolaflexin® and ...
more»
There are currently no comments on this topic.
Be the first person to Add a Comment...
You must be a registered user to post a comment: REGISTER NOW
If you are already registered, please LOGIN NOW
|
Code | Last | Change |
COMP | 10,321 | 328 | | 3.08% |
DJI | 29,635 | 404 | | 1.34% |
SP500 | 3,583 | 87 | | 2.37% |
DAX | 12,438 | 82 | | 0.67% |
FTSE | 7,488 | 5 | | 0.07% |
NI225 | 22,420 | 408 | | 1.86% |
TWI | 67.27 | 0.00 | | 0.00% |